Alessandro Di Minno

Ceinge Biotecnologie Avanzate (Italy)

Papers

1

Total Citations

47

H-Index

1

About

Alessandro Di Minno is a clinical researcher whose work focuses on the intersection of oxidative stress, urological oncology, and biomarker discovery. His major contributions center on identifying and validating non-invasive urinary markers to assess cellular damage in prostate cancer patients. In his most cited work, he demonstrated that elevated levels of 8-hydroxy-2-deoxyguanosine (8-OHdG) and 8-iso-prostaglandin F2α (8-IsoF2α) serve as putative biomarkers for oxidative stress following robot-assisted radical prostatectomy (RARP), offering new insights into the molecular aftermath of surgical intervention. This study, which has garnered 47 citations, highlights his ability to bridge translational biochemistry with clinical practice. Di Minno’s research is particularly impactful for its potential to refine diagnostic panels and improve post-surgical monitoring in oncology. His work is notable for its rigorous methodology and its contribution to the growing field of redox biology in cancer care, making him a valuable voice for students and researchers interested in precision medicine and the role of oxidative damage in disease progression.

Research Focus

Key Achievements

1
H-Index
1
Papers
47
Total Citations
47
Avg Citations/Paper
🏆 Most Cited Paper
8-Hydroxy-2-Deoxyguanosine and 8-Iso-Prostaglandin F2α: Putative Biomarkers to assess Oxidative Stress Damage Following Robot-Assisted Radical Prostatectomy (RARP)
47 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Ceinge Biotecnologie Avanzate (Italy)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago